OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
METTL3-stabilized lncRNA SNHG7 accelerates glycolysis in prostate cancer via SRSF1/c-Myc axis
Jun Liu, Junfang Yuan, Yuzhong Wang
Experimental Cell Research (2022) Vol. 416, Iss. 1, pp. 113149-113149
Closed Access | Times Cited: 44
Jun Liu, Junfang Yuan, Yuzhong Wang
Experimental Cell Research (2022) Vol. 416, Iss. 1, pp. 113149-113149
Closed Access | Times Cited: 44
Showing 1-25 of 44 citing articles:
m6A-regulated tumor glycolysis: new advances in epigenetics and metabolism
Shiwei Yue, Hailing Liu, Hong-Fei Su, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 42
Shiwei Yue, Hailing Liu, Hong-Fei Su, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 42
RNA modifications in cellular metabolism: implications for metabolism-targeted therapy and immunotherapy
Weiwei Liu, Si-Qing Zheng, Li Tian, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 32
Weiwei Liu, Si-Qing Zheng, Li Tian, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 32
Critical roles and clinical perspectives of RNA methylation in cancer
Ganglei Li, Qinfan Yao, Peixi Liu, et al.
MedComm (2024) Vol. 5, Iss. 5
Open Access | Times Cited: 17
Ganglei Li, Qinfan Yao, Peixi Liu, et al.
MedComm (2024) Vol. 5, Iss. 5
Open Access | Times Cited: 17
The roles of N6-methyladenosine and its target regulatory noncoding RNAs in tumors: classification, mechanisms, and potential therapeutic implications
Ziying Liu, Lei Gao, Long Cheng, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 3, pp. 487-501
Open Access | Times Cited: 37
Ziying Liu, Lei Gao, Long Cheng, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 3, pp. 487-501
Open Access | Times Cited: 37
Emerging role of RNA modification and long noncoding RNA interaction in cancer
Liqiong Yang, Lu Tang, Qi Min, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 6, pp. 816-830
Open Access | Times Cited: 8
Liqiong Yang, Lu Tang, Qi Min, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 6, pp. 816-830
Open Access | Times Cited: 8
New roles of N6-methyladenosine methylation system regulating the occurrence of non-alcoholic fatty liver disease with N6-methyladenosine-modified MYC
Wenli Cheng, Min Li, Luyun Zhang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 34
Wenli Cheng, Min Li, Luyun Zhang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 34
Importance of long non-coding RNAs in the pathogenesis, diagnosis, and treatment of prostate cancer
Mohammad Taheri, Elham Badrlou, Bashdar Mahmud Hussen, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 16
Mohammad Taheri, Elham Badrlou, Bashdar Mahmud Hussen, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 16
The role of the methyltransferase METTL3 in prostate cancer: a potential therapeutic target
Xuming Zhou, Keqiang Chai, Hezhen Zhu, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 7
Xuming Zhou, Keqiang Chai, Hezhen Zhu, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 7
RNA N6-methyladenosine modifications in urological cancers: from mechanism to application
Lei Yang, Jianming Ying, Qian Tao, et al.
Nature Reviews Urology (2024) Vol. 21, Iss. 8, pp. 460-476
Closed Access | Times Cited: 6
Lei Yang, Jianming Ying, Qian Tao, et al.
Nature Reviews Urology (2024) Vol. 21, Iss. 8, pp. 460-476
Closed Access | Times Cited: 6
Exosome-derived lncRNA A1BG-AS1 attenuates the progression of prostate cancer depending on ZC3H13-mediated m6A modification
Zhi Yang, Yu Luo, Fan Zhang, et al.
Cell Division (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 6
Zhi Yang, Yu Luo, Fan Zhang, et al.
Cell Division (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 6
Zhaotong Wang, Jiawang Zhou, Haisheng Zhang, et al.
Molecular Oncology (2022) Vol. 17, Iss. 2, pp. 195-229
Open Access | Times Cited: 27
METTL3: a multifunctional regulator in diseases
Na Li, Wei Xiang, J.J. Dai, et al.
Molecular and Cellular Biochemistry (2025)
Closed Access
Na Li, Wei Xiang, J.J. Dai, et al.
Molecular and Cellular Biochemistry (2025)
Closed Access
FOXD2-AS1 is modulated by METTL3 with the assistance of YTHDF1 to affect proliferation and apoptosis in esophageal cancer
Z. Wang, X Liu, Zhengya Gao, et al.
Acta Pharmaceutica (2025) Vol. 75, Iss. 1, pp. 69-86
Open Access
Z. Wang, X Liu, Zhengya Gao, et al.
Acta Pharmaceutica (2025) Vol. 75, Iss. 1, pp. 69-86
Open Access
Shoubin Cui
Journal of Clinical Laboratory Analysis (2022) Vol. 36, Iss. 12
Open Access | Times Cited: 20
The relationship between the network of non-coding RNAs-molecular targets and N6-methyladenosine modification in tumors of urinary system
Ruiming Li, Zhu Chunming, Yuan Wang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 4
Open Access | Times Cited: 4
Ruiming Li, Zhu Chunming, Yuan Wang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 4
Open Access | Times Cited: 4
METTL3 facilitates prostate cancer progression via inducing HOXC6 m6A modification and stabilizing its expression through IGF2BP2-dependent mechanisms
Peng He, Xuehui Liu, Yu Gui, et al.
Molecular and Cellular Biochemistry (2024) Vol. 479, Iss. 7, pp. 1707-1720
Closed Access | Times Cited: 4
Peng He, Xuehui Liu, Yu Gui, et al.
Molecular and Cellular Biochemistry (2024) Vol. 479, Iss. 7, pp. 1707-1720
Closed Access | Times Cited: 4
Bibliometric analysis of glycolysis and prostate cancer research from 2004 to 2024
Congxu Zhu, Jingjing Yang, Lumei Liu, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Congxu Zhu, Jingjing Yang, Lumei Liu, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Tumor-promoting effect and tumor immunity of SRSFs
Shuai Zhang, Yongxi Zhang, Sijia Feng, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Shuai Zhang, Yongxi Zhang, Sijia Feng, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
METTL3 Promotes the Growth and Invasion of Melanoma Cells by Regulating the lncRNA SNHG3/miR-330-5p Axis
Shaojun Chu, Yulong Li, Baojin Wu, et al.
Cell Transplantation (2023) Vol. 32
Open Access | Times Cited: 10
Shaojun Chu, Yulong Li, Baojin Wu, et al.
Cell Transplantation (2023) Vol. 32
Open Access | Times Cited: 10
The dysregulation of lncRNAs by epigenetic factors in human pathologies
Yanli Zhang, Xiaocong Wang, Chen Zhang, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 9, pp. 103664-103664
Closed Access | Times Cited: 9
Yanli Zhang, Xiaocong Wang, Chen Zhang, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 9, pp. 103664-103664
Closed Access | Times Cited: 9
Xu‐Sheng Liu, Yu Zhang, Zi‐Yue Liu, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 6
Open Access | Times Cited: 3
Analysis of disulfidptosis‐ and cuproptosis‐related LncRNAs in modulating the immune microenvironment and chemosensitivity in colon adenocarcinoma
Qiang Fan, Guangbo Wu, Min Chen, et al.
IET Systems Biology (2024) Vol. 18, Iss. 2, pp. 55-75
Open Access | Times Cited: 3
Qiang Fan, Guangbo Wu, Min Chen, et al.
IET Systems Biology (2024) Vol. 18, Iss. 2, pp. 55-75
Open Access | Times Cited: 3
A comprehensive insight into the role of small nucleolar RNAs (snoRNAs) and SNHGs in human cancers
Huldani Huldani, Kumaraswamy Gandla, Mohammed Asiri, et al.
Pathology - Research and Practice (2023) Vol. 249, pp. 154679-154679
Closed Access | Times Cited: 8
Huldani Huldani, Kumaraswamy Gandla, Mohammed Asiri, et al.
Pathology - Research and Practice (2023) Vol. 249, pp. 154679-154679
Closed Access | Times Cited: 8
RNA m6A modification in prostate cancer: A new weapon for its diagnosis and therapy
Zeyu Han, Xianyanling Yi, Jin Li, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 5, pp. 188961-188961
Closed Access | Times Cited: 7
Zeyu Han, Xianyanling Yi, Jin Li, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 5, pp. 188961-188961
Closed Access | Times Cited: 7
Jinghua Gu, Huake Cao, Xiaoli Chen, et al.
Wiley Interdisciplinary Reviews - RNA (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 7
